Current and future trends in coagulation management for congenital heart surgery.
Arthur S. Keats Division of Pediatric Cardiovascular Anesthesiology and Department of Anesthesiology, Texas Children's Hospital; and Department of Anesthesiology Baylor College of Medicine, Houston, Tex. Electronic address: eagottli@texaschildrens.org.
Erin A
EA
Gottlieb
Arthur S. Keats Division of Pediatric Cardiovascular Anesthesiology and Department of Anesthesiology, Texas Children's Hospital; and Department of Anesthesiology Baylor College of Medicine, Houston, Tex.
Dean B
DB
Andropoulos
D000367:Age Factors; D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion / Q000379:methods*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D016903:Drug Monitoring / Q000379:methods; D006330:Heart Defects, Congenital / Q000097:blood / Q000175:diagnosis / Q000601:surgery*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D019106:Postoperative Hemorrhage / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents